Biosimilars 7: PBMs and Payer Policies

In the seventh and final course in the Biosimilars Continuing Education Series entitled "Biosimilars - PBMs and Payer Policies", Madelaine Feldman, MD, FACR explains unique features of the U.S. drug distribution system, with an emphasis on payer and pharmaceutical benefit manager (PBM) practices regarding biologic medicines and biosimilars.

After completing this program, the participant should be able to:

1. Discuss the role of pharmaceutical benefit managers (PBMs) in the U.S. drug distribution system.
2. Explain the effects of competition on drug pricing under provider-administered and patient-administered drugs.
3. Identify several utilization management techniques used by PBMs to influence which medicine the patient receives.
4. Describe concerns that patients and physicians have regarding these PBM practices.
5. Discuss potential legislative approaches under consideration to address concerns with PBM practices.

The College of Pharmacy at The Ohio State University is accredited by the Accreditation Councel for Pharmacy Education as a provider of continuing pharmacy education. This program is approved for 1.0 contact hours (0.1 CEU) under the ACPE universal program number 0633-0000-23-005-H04-P. Participants must view the video, achieve an 80% on the quiz and complete the evaluation to receive CE credit for program. Questions about pharmacist's participation in the program and continuing education credit should be addressed to Brooke Keber at cop-cpd@osu.edu.